Abstract
Purpose
We aimed to establish a rabbit model with retinal atrophy induced by an iatrogenic retinal pigment epithelium (RPE) removal, for future testing of the efficacy and safety of cell therapy strategies.
Methods
A localized detachment of the retina from the RPE/choroid layer was created in 18 pigmented rabbits. The RPE was removed by scraping with a custom-made extendable loop instrument. The resulting RPE wound was observed over a time course of 12 weeks with optical coherence tomography and angiography. After 4 days (group 1) and 12 weeks (group 2), histology was done and staining with hematoxylin and eosin, as well as immunofluorescence performed to further investigate the effects of debridement on the RPE and the overlying retina.
Results
Already after 4 days, we observed a closure of the RPE wound by proliferating RPE and microglia/macrophage cells forming a multilayered clump. This pattern continued over the observation time course of 12 weeks, whereby the inner and outer nuclear layer of the retina became atrophic. No neovascularization was observed in the angiograms or histology. The observed changes were limited to the site of the former RPE wound.
Conclusions
Localized surgical RPE removal induced an adjacent progressive retinal atrophy. Altering the natural course of this model may serve as a basis to test RPE cell therapeutics.
Similar content being viewed by others
Introduction
The majority of age-related macular degeneration (AMD) patients have no effective treatment option available. While neovascular forms of AMD can now be effectively treated by repetitive injections of vascular endothelial growth factor (VEGF) inhibitors for preventing further loss of vision, no therapy is available for the dry late manifestation (geographic atrophy) [1]. A common denominator of the disease seems the impairment of the retinal pigment epithelium (RPE), a cell monolayer located between the choroid and photoreceptors and superimposed on a thin, acellular, five-layered extra cellular matrix called Bruch’s membrane (BM) [2]. The replacement of these dysfunctional or lost submacular RPE cells therefore represents a meaningful therapeutic goal [3,4,5].
Various clinical treatment concepts with RPE replacement have been tried so far, such as macular translocation, peripheral RPE cell suspensions, and autologous RPE/choroidal grafts [3, 4, 6, 7]. However, either no or only limited visual acuity improvements have been achieved [4].
Recently, novel methods to transplant pluripotent stem cell-derived RPE cells (PSC-RPE) have become available, either as a cell suspension or as a bioengineered monolayer [2]. In this context, it is worth noting that a US FDA Phase 1/2 clinical trial on transplantation of human embryonic stem cell-derived RPE cells (hES-RPE) suspensions into patients with advanced dry AMD has been completed at several US centers [8, 9]. Other clinical studies were conducted showing the survival and integration of PSC-RPE delivered under the retina on a patch [10,11,12,13].
So far, ongoing clinical studies with stem cell-derived RPE replacement in atrophic AMD have conducted the transplantation on to an intact, but presumably less functional, RPE in the so-called transition zone. From many points of view, it is desirable to perform a complete replacement of the degenerated RPE with a healthy RPE graft. In a mouse RPE toxicity model for example, it was shown that sodium iodate-necrosed host RPE cells could be completely replaced as a single layer by xenotransplantation of a hES-RPE suspension [14]. Since it is highly unlikely that sodium iodate or other RPE toxic substances would be used to remove the dysfunctional RPE, local measures are needed to remove the RPE in the graft target area. For this purpose, we have developed a simple instrument that has been successfully tested in three species (rabbit, pig, and monkey) [15]. Although our instrument has proven to be effective in short-term experiments [16], a subretinal injection of viscoelastics was needed to eliminate its flute needle effect.
The aim of this animal experiment series was to characterize a rabbit model with circumscribed retinal and choroidal atrophy surrounding the area of the created RPE wound using an improved instrument to enable testing of RPE cell therapeutics in future.
Materials and methods
Animals
We purchased 18 female and male Dutch Belted rabbits weighing 2 to 2.5 kg (Covance Research Products, Denver/PA, USA). All procedures were approved by the state regulatory authorities of Belgium study code 18–080 and were in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. Animals were held indoors in a specialized facility in an air-conditioned room with temperatures between 18 °C and 20 °C, exposure to 12 h of daylight, in standardized individual cages with free access to food and water.
Study design
Animals were divided into 2 groups, depending on follow-up time (Table 1). In 15 rabbits, native RPE was removed by scraping, whereas in 3 animals the RPE was left untouched serving as a control. After surgery, follow-up examinations were performed after 4 days, 1, 2, 4, and 12 weeks post-operatively using scanning laser ophthalmoscopy and spectral domains of optical coherence tomography (SLO/SD-OCT), fluorescein angiography (FA), and indocyanine green angiography (ICGA) (Spectralis®, Heidelberg Engineering, Germany). For histological examination, 8 animals were euthanized after their last examination on day 4 and the remaining 10 animals were euthanized 12 weeks after surgery.
Surgery
As shown in Fig. 1 and Vid. S1, 18 Dutch Belted rabbits (2–2.5 kg) underwent surgery after intravenous induction of general anesthesia with ketamine (25 mg/kg) and xylazine (2 mg/kg). Triamcinolone-assisted, 25 gauge (G) 3 port vitrectomy was performed in the left eye, including induction of a posterior vitreous detachment. Subsequently, 1–2 localized circumscribed, bleb-shaped retinal detachments (bRD) were created by manual subretinal injection of 20–30 μL balanced salt solution (BSS) via a 25/38 G subretinal cannula (MedOne Surgical Inc., Sarasota/ FL, USA) connected to a 100 μL syringe (Hamilton Germany GmbH, Gräfelfing, Germany). A roughly 1.5 mm wide retinotomy was made using 23 G vertical retinal scissors (Geuder, Heidelberg, Germany) after which a RPE wound was created by scraping with a custom sling instrument made from prolene suture material (Geuder, Heidelberg, Germany) (Vid. S2) [16]. An intraocular tamponade was not required.
Post-operative SLO/SD-OCT imaging
The rabbit was anesthetized, and pupils dilated as above. Application of a corneal lubricant (Optive®, Allergan, Frankfurt, Germany) was done at least every 5 min to moisturize the eye and maintain clear SD-OCT imaging; then, we attached a steel platform to the headrest to stabilize the animal in the required position. We used a 30-degree lens and the following parameters for optimal optical coherence tomography (OCT) imaging: 30 degrees settings for single line scans with automated real-time tracking (ART) mode set to 100 (averaging) and 20 × 20 degree settings for volume scans with ART mode set to 15; high resolution mode was not required. SLO infrared reflectance imaging aided us in finding the focal plane of the RPE-wound.
Post-operative FA and ICGA
Following the SD-OCT, while still under anesthesia and similar positioning as described above, 0.2 mL sodium fluorescein solution (10%) (Alcon Pharma GmbH, Freiburg, Germany) and 0.5 mL containing 1.25 mg of indocyanine green (Diagnostic Green GmbH, Aschheim-Dornach, Germany) were injected in the marginal ear vein, and the images were captured immediately. Late-phase photos were acquired at every minute for a period of at least 15 min. Recordings of FA and ICGA were done separately to ensure optimal focus. We used a 30-degree lens, we acquired movies of early stages, followed by single images, while using the ART mean function for late/dark images. For ICGA, we reduced the laser intensity to 25–50% to acquire the early stages and returned it to 100% after ca. 2–3 min. After finishing the examination, we added dexamethasone 1 mg/g, neomycin sulfate 3,500 I.U./g, and polymyxin B sulfate 6,000 I.U./g ointment under the lid.
Histologic sample collection
Following the last post-operative examination with SLO/SD-OCT at 4 days or 12 weeks after surgery (N = 8 at 4 days, 10 at 12 weeks), the animals were euthanized with 5 mL T61 (Intervet Deutschland GmbH, Unterschleißheim, Germany) in deep anesthesia as per above protocol. The heads were fixed via carotid-perfusion with 4% paraformaldehyde (PFA), buffered with 0.2 M phosphate buffered saline at pH 8.5. Eyes were enucleated and full thickness specimen (sclera, choroid, and retina) and then were prepared from the bleb areas with (N = 30) and without (N = 6) RPE manipulation; five RPE scraped regions were not sampled, as the scraping site was not well identifiable in hematoxylin and eosin (HE) staining and the histology did not match the corresponding OCT images. Two control regions from one right eye that did not undergo surgery were also prepared.
Histological processing and photomicroscopy
The specimens were embedded in paraffin and cut into 5-µm thick sections. For morphological assessment, HE staining was performed. Pictures were taken on an Olympus IX71 microscope with an Olympus Dp72 camera.
Immunofluorescence staining was performed as follows: after dewaxing, the slides were placed in boiling citrate buffer, pH 6, and cooked for further 15 min in the microwave at 600 W to retrieve antigens. Before staining, the slides were allowed to cool down to room temperature for 20 min and then rinsed with tap water. Sections were transferred into a dark humid chamber, washed three times for 3 min each with Tris-buffered saline (TBS) with 0.1% Tween 20 (Sigma-Aldrich, Taufkirchen, Germany) (TBST) and then blocked with 5% Bovine Serum Albumin (BSA; VWR International GmbH, Darmstadt, Germany) in TBS for 45 min at room temperature. Primary antibodies and isolectin B4 were applied to the sections and incubated overnight at + 4 °C. The antibodies and isolectin B4 (IB4) were diluted in 1% BSA in TBS (Table 2). The next day, sections were brought to room temperature before continuing with washing as before and applying the secondary antibodies anti-mouse immunoglobulin G (IgG) Cy5 and anti-rabbit IgG Alexa647 (both Invitrogen, Carlsbad, CA, USA) 1:200 in 1% BSA in TBS for 1 h at room temperature in the dark humid chamber. Then, sections were washed three times for 3 min in TBST and nuclei were stained with 1 µg/mL 4′, 6-diamidino-2-phenylindole (DAPI; Invitrogen, Carlsbad, CA, USA) in TBS for 5 min. A last washing step for 5 min with TBS was done before sections were mounted with Shandon Immumount (Fisher Scientific, Schwerte, Germany). Fluorescence pictures were taken with a white light confocal laser scanning microscope (CLSM; TCS SP8, Leica Microsystems, Wetzlar, Germany). Microscope images were arranged with ImageJ 1.52p (National Institute of Health, USA) and overview images of the retina were generated with the Stitching plugin in ImageJ [17]. Staining controls are found in Fig. S1.
Results
Improvement of surgical RPE removal technique
We successfully operated all 18 animals and induced a total of 36 bRDs. The RPE underneath the bRD was removed by scraping in 30 cases with a revised loop instrument. The major improvement to our previously published loop instrument [16] is that no subretinal viscoelastic is required for RPE ablation. We were able to eliminate the instrument’s flute needle effect that causes bleb collapse due to passive fluid drainage via tip and handle of the instrument as a result of the intraoperative pressure gradient from inside versus outside the eye. With up to 3 brushes, it was possible to create a 5–9 mm2 RPE wound. In continuation of our previous work, we now investigated the effects of RPE removal up to 12 weeks.
Short-term effects of RPE debridement
At follow-up on post-operative day 4, the optical media of the rabbits’ eyes were clear, with little post-operative inflammation. In the respective SD-OCT scans, the retina overlying the iatrogenic RPE wound showed an RPE irregularity and lacked intact ellipsoidal bands (Fig. 2A). By contrast, when the RPE was not scraped, an ellipsoid zone and RPE band remained distinguishable. An OCT of a normal rabbit retina before surgery is depicted in Fig. 3C and Fig. S2.
Angiographic examination of the retina showed a hyperfluorescence in FA and ICGA late phase at the site of the RPE wound (Fig. 4A–C, F), suggesting perfusion in the choriocapillaris. SD-OCT angiography obtained with the Spectralis 2 device (Heidelberg Engineering, Germany) failed due to motion artifacts (data not shown) and was therefore discontinued in subsequent follow ups. Choroidal thickness on SD-OCT was not altered in RPE wound areas versus unoperated regions. There was no sign of leakage in FA or branching vascular networks on ICGA, indicating that the surgical removal did not induce a choroidal neovascularization (CNV).
Histological assessment of the specimens 4 days after surgery showed atrophic retinal regions above the areas where RPE was removed (Fig. 5). Especially the outer layers are affected which show photoreceptor degeneration and outer nuclear layer (ONL) thinning corresponding to the region of RPE removal. The limits of the RPE wound and where the healthy RPE begins could be nicely visualized by SD-OCT scan and the corresponding HE staining. Immunofluorescence staining for panCK showed already RPE cells that were repopulating the scraped site. These RPE cells exhibit only a weak ZO-1 staining, a marker for tight-junctions.
Normally, microglia reside in a quiescent state in the inner plexiform layer [18] (Fig. 5). Cell proliferation is seen at the RPE wound and to some extent at the margins of the retinotomy (Fig. 5 and Fig. S3). By using IB4 staining, we could see the presence of microglia and/or (monocyte derived) macrophages. Ki67 was used to assess cell proliferation and at the site of the RPE wound it colocalizes in part with microglia/macrophages. However, as no colocalization of panCytokeratin and Ki67 staining was shown, this suggests no involvement of RPE at the 4 days timepoint. The source of the collagen IV deposition is unclear, but colocalizes in some part with the proliferating microglia/macrophages (Fig. 5 and Fig. S3).
Long-term effects of RPE debridement
In the following 12 weeks, we saw a complete closure of the retinotomy, increasing atrophy of the retina, and a hypertrophy of the RPE in OCT follow-up exams (Fig. 2B–E).
In the angiographic displays at 12 weeks after surgery, only subtle hyperfluorescence in the late phase of the FA could be shown in the scraping area (Fig. 6). The choriocapillaris could not be visualized satisfactorily over time due to blockage of the FA/ICG signal by accumulated pigment (Fig. 6).
In the respective histology, the atrophy of the retina progressed in all 13 scraping sites up to the inner retinal layers. The choriocapillaris contained some scattered erythrocytes and the overlying Bruch’s membrane appeared contiguous on HE stainings (Fig. 7A and B). Microglia/macrophages lineages, which invaded the subretinal space in the first week after surgery, were not detectable at 12 weeks by IB4 (Fig. 8). In addition, the proliferation at the site of the RPE wound appeared to have ceased, as Ki67 signals were missing (Fig. 8). Vascular endothelial cells also stained by IB4 did not form vessel-like structures beyond the integer BM and the RPE layer (Fig. 8), confirming the observation made before in the OCT and angiography. Thus, this surgical manipulation did not lead to CNV formation, neither in the short-term nor in the long-term histological specimens (Figs. 5 and 8, respectively).
Interestingly, already 4 days after RPE removal, the wound has almost closed. However, the newly formed RPE cells beneath the retinotomy are hypertrophic. This appearance is unaltered after 12 weeks (Fig. 7C). We assessed the functionality of these cells by staining for ZO-1, which is an intracellular protein located at the apical tight junctions and is often used as a marker for correct epithelial polarity [19]. After 4 days, there is no ZO-1 staining at the site of the RPE wound, but in transition to the native RPE, it is expressed and mainly seen at the apical surface facing the photoreceptor layer (Fig. 9). After 12 weeks, the multi-layered RPE beneath the atrophic photoreceptor layer does express ZO-1, but there is no polarization visible. This phenotype extends also to the edge of the wound, where the ONL has a normal morphology (Fig. 9).
In our control group with a bRD without scraping after 12 weeks, a central pigment epithelial hypertrophy was observed only around the retinotomy (Fig. 10A, B, and F). We also saw cell proliferation in the RPE layer (Fig. 10C) that was not scraped during surgery, as well as few infiltrating microglia or macrophages in the outer nuclear layer and even more in the inner nuclear layer, where we also found ongoing cell proliferation (Fig. 10B and C). The collagen IV staining shows also only minor deposits in the ONL (Fig. 10 G). Confirming that the induction of a retinal detachment alone activates retinal wound healing processes [20].
Discussion
We aimed to develop a localized outer retinal atrophy model induced by RPE removal to enable the translational preclinical animal studies of RPE cell therapeutics. While in our previous study on acute effects of surgical RPE removal, photoreceptor outer segments (POS) were intact [16], and we now saw atrophy of the ONL in all samples at 4 days and 3 months. This loss is attributed to the removal of the RPE layer since the generation of a bRD alone in our control did not lead to atrophy of the ONL. This was also reported in another study where long-term effects of bRDs alone in the rabbit retina were evaluated [21]. By contrast, Szurman et al. [22] reported that the immediate effects of a bRD are RPE monolayer disruption and torn POS. Similar results were also seen by another group [23]. Differences in surgical technique may explain the discrepancy between these outcomes, e.g., we utilize a 0.1–0.25 mL Hamilton syringe vs. 1 mL syringe, low intraocular pressure (IOP) in a valved and sutured port 25G system vs. 20G 3 port sclerotomy PPV, and complete removal of the cortical vitreous vs. just core vitrectomy. In the merangiotic retina of the rabbit, only a small part of the retinal nutritional supply comes from blood vessels, and photoreceptors are therefore dependent on RPE cells to supply nutrients and waste disposal (i.e., phagocytosis of POS), in addition to the other functions of the RPE cells in maintaining a healthy retinal environment [21]. With this observation, we met our first aim to generate a rabbit model for loss of photoreceptors due to a removed RPE.
To date, our group had the opportunity to perform similar techniques on 5 different rabbit strains, including chinchilla bastard, Chinchilla bastard/KBL hybrids, New Zealand White/Red Cross, New Zealand White (albino), and Dutch belted. Both male and female rabbits were operated on, while we did not register any gender specific differences in our results. For our experiments, we chose the Dutch belted strain having retinal pigmentation to allow contrast appreciation during subretinal implantation. It has also a thick sclera and larger eye volumes making the operation smoother. The histologic analysis revealed already 4 days after surgery a hypertrophic RPE cell layer that had grown back to close the surgically induced RPE wound. These RPE cells have an abnormal appearance, as we observed multi-layering and even after 12 weeks still a mounded appearance, which could be accompanied by at least a partial loss of function. A similar observance was made by Ivert et al. [21] after induction of a bRD without further manipulating the RPE layer. They demonstrated in their follow-up examinations the mounded appearance of the RPE cells after this surgery and that it induces breakdown of the blood-retinal-barrier, a crucial function of the RPE. The RPE is quite sensitive to changes in its microenvironment through so-called dynamic reciprocity reactions with the extracellular matrix [24], which might be the reason why the RPE cells, which closed the induced wound already after 4 days, have not yet regained their normal appearance after 12 weeks. During this wound-healing process, RPE cells might undergo epithelial-mesenchymal transition (EMT), where they lose their epithelial phenotype by rearrangement of their cytoskeleton, loss of cell–cell contacts, and polarity [25]. We attempted to asses polarity by ZO-1 staining and indeed did not observe a RPE monolayer with apical ZO-1 expression, as it would be in native RPE [19]. With our results, we cannot exclude that at least a partial EMT has occurred, as cytokeratins are conserved proteins of the RPE cytoskeleton [26], and the expression of the tight-junction protein ZO-1 was weak. For a clarification of these processes, in situ analysis of the transcriptional profile of the RPE would be needed.
Dying photoreceptors release damage-associated molecular patterns (DAMPs), such as HMGB1 [27], which activate innate immune cells and microglia. Arroyo et al. [28] showed that the peak of photoreceptor death in humans after retinal detachment was found around day 2, perhaps explaining why staining of our day 4 histologic samples for Caspase 3 yielded no signal. In steady state, microglia have a ramified appearance and reside in the plexiform layers where they scan the retinal environment. Upon activation, they change to an amoeboid form and migrate toward the relevant site [18]. Indeed, we could identify the presence of IB4-positive cells in the space between photoreceptors and choroid in the early post-operative phase colocalizing with strong collagen IV depositions (Fig. 5), but after 3 months, these cells were again mainly detectable in the IPL (Fig. 8, upper panel). It could be both microglia and macrophages, as both cell types are stained by IB4 and in general share common markers. It is most likely that the cells observed in the photoreceptor layer are microglia, as in a study of retinal detachment in cats macrophages were detected only in the subretinal space and did not infiltrate the retinal layers [20]. The advantage of the cat model in this case was that microglia in cats are negative for CD11b and, therefore, allow for the discrimination of these two cell types. Our experimental setup does not allow to determine the origin of the collagen IV depositions, given only 2 histologic time points were sampled. Wickham et al. observed also an invasion of microglia to the outer retina layers as well as an increasing number of GFAP-positive cells (astrocytes and Müller glia) with protrusions into the outer retinal layers after retinal detachment [29]. In another study, the same group also found ongoing proliferation activity in Müller cells and the activated microglia by BrdU labeling [30].
Technologies for RPE debridement have been described by other groups, such as hydraulic debridement [31]. This method showed promising results albeit with possible Bruch’s membrane breaks, yet no choroidal or inner retinal damage. The main setback of this method was the high rate of epiretinal membranes and proliferative vitreoretinopathy with rhegmatogenous retinal detachment in up to 20% of the cases in the 28 and 56 day groups [31]. Other groups attempting this method had further complications such as macroscopic [32] and microscopic [33] hemorrhages, fibrin, and cellular damage of the neural retina with intracellular edema [32]. Petrus-Reurer et al. [34] suggested a debridement with a subretinal injection of 50 µL sodium iodate causing RPE hyperautofluorescence, focal RPE loss, and choroidal atrophy and thereby mimicking the retina of a patient with geographic atrophy, yet even in the lowest dosage of 0.1 mM of sodium iodate caused a loss of the ellipsoid zone and outer limiting membrane bands as well as a thinning of the outer nuclear layer, even though the RPE cells were still intact [34]. Other studies also document the retinal toxicity of sodium iodate [35], thus banning its potential use in patients. In the former laboratory, outer retinal damage occurred also while subretinally injecting 50 µL BSS (= vehicle), confirming iatrogenic mechanical damage from their earlier report [23]. As discussed previously, we tried to overcome this problem by injecting a less amount of BSS (20–30 µL), as slow as possible, resulting in a flatter yet wide bRD, thereby reducing retinal stretching and photoreceptor damage (Fig. 9).
The rabbit model described here may serve as a reproducible and cost-efficient model for testing various stem cells derived therapies. Several studies have shown that rabbit models are suitable for evaluating human-derived stem cell therapy [36,37,38]. Even though functionality and survivability of human-derived RPE cells have been studied, one limitation of retinal atrophy models in rabbits is its merangiotic retina, which is distinguished by lack of retinal vessels as seen in Fig. 1a. This causes a faster and more severe atrophy than in animals with blood supply to the peripheral retina, yet this might be overcome by directly implanting RPE cells after scraping. Another limitation of the study is that the scraping was performed on healthy RPE without drusen or RPE-clumping and, therefore, may not be translatable into clinical trials due to safety concerns. Still, we were able to develop an improved large animal model for RPE debridement with minimal iatrogenic damage. This will form the basis for subsequent investigations with specific cell transplantations and carrier models. Future studies will investigate the survival und functionality of stem cell-derived RPE cells as a monolayer on a carrier or as suspension delivered to the RPE-wound and their effect on the above lying retina.
Data availability
Not applicable.
Code availability
Not applicable.
References
Schmidt-Erfurth UM, Pruente C (2007) Management of neovascular age-related macular degeneration. Prog Retin Eye Res 26:437–451. https://doi.org/10.1016/j.preteyeres.2007.03.002
Zarbin M, Sugino I, Townes-Anderson E (2019) Concise review: update on retinal pigment epithelium transplantation for age-related macular degeneration. Stem Cells Transl Med 8:466–477. https://doi.org/10.1002/sctm.18-0282
Binder S, Stanzel BV, Krebs I, Glittenberg C (2007) Transplantation of the RPE in AMD. Prog Retin Eye Res 26:516–554. https://doi.org/10.1016/j.preteyeres.2007.02.002
da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P (2007) RPE transplantation and its role in retinal disease. Prog Retin Eye Res 26:598–635
Jin ZB, Gao ML, Deng WL, Wu KC, Sugita S, Mandai M, Takahashi M (2019) Stemming retinal regeneration with pluripotent stem cells. Prog Retin Eye Res 69:38–56. https://doi.org/10.1016/j.preteyeres.2018.11.003
Chen FK, Uppal GS, MacLaren RE, Coffey PJ, Rubin GS, Tufail A, Aylward GW, Da Cruz L (2009) Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration. Clin Exp Ophthalmol 37:275–285. https://doi.org/10.1111/j.1442-9071.2009.01915.x
van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC (2012) Am J Ophthalmol 153:120-127.e122. https://doi.org/10.1016/j.ajo.2011.06.007
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379:713–720. https://doi.org/10.1016/S0140-6736(12)60028-2
Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385:509–516. https://doi.org/10.1016/S0140-6736(14)61376-3
da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ (2018) Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol 36:328–337. https://doi.org/10.1038/nbt.4114
Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, Go MJ, Shinohara C, Hata KI, Sawada M, Yamamoto M, Ohta S, Ohara Y, Yoshida K, Kuwahara J, Kitano Y, Amano N, Umekage M, Kitaoka F, Tanaka A, Okada C, Takasu N, Ogawa S, Yamanaka S, Takahashi M (2017) Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med 376:1038–1046. https://doi.org/10.1056/NEJMoa1608368
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin CM, Mitra D, Zhu D, Thomas BB, Hikita ST, Pennington BO, Johnson LV, Clegg DO, Hinton DR, Humayun MS (2018) A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Sci Transl Med 10(435):eaao4097. https://doi.org/10.1126/scitranslmed.aao4097
Sugita S, Mandai M, Hirami Y, Takagi S, Maeda T, Fujihara M, Matsuzaki M, Yamamoto M, Iseki K, Hayashi N, Hono A, Fujino S, Koide N, Sakai N, Shibata Y, Terada M, Nishida M, Dohi H, Nomura M, Amano N, Sakaguchi H, Hara C, Maruyama K, Daimon T, Igeta M, Oda T, Shirono U, Tozaki M, Totani K, Sugiyama S, Nishida K, Kurimoto Y, Takahashi M (2020) HLA-matched allogeneic iPS cells-derived RPE transplantation for macular degeneration. J Clin Med 9(7):2217. https://doi.org/10.3390/jcm9072217
Carido M, Zhu Y, Postel K, Benkner B, Cimalla P, Karl MO, Kurth T, Paquet-Durand F, Koch E, Munch TA, Tanaka EM, Ader M (2014) Characterization of a mouse model with complete RPE loss and its use for RPE cell transplantation. Invest Ophthalmol Vis Sci 55:5431–5444. https://doi.org/10.1167/iovs.14-14325
Stanzel B, Ader M, Liu Z, Amaral J, Aguirre LIR, Rickmann A, Barathi VA, Tan GSW, Degreif A, Al-Nawaiseh S, Szurman P (2019) Surgical approaches for cell therapeutics delivery to the retinal pigment epithelium and retina. Adv Exp Med Biol 1186:141–170. https://doi.org/10.1007/978-3-030-28471-8_6
Thieltges F, Liu Z, Brinken R, Braun N, Wongsawad W, Somboonthanakij S, Herwig M, Holz FG, Stanzel BV (2016) Localized RPE removal with a novel instrument aided by viscoelastics in rabbits. Transl Vis Sci Technol 5:11. https://doi.org/10.1167/tvst.5.3.11
Preibisch S, Saalfeld S, Tomancak P (2009) Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 25:1463–1465. https://doi.org/10.1093/bioinformatics/btp184
Rashid K, Akhtar-Schaefer I, Langmann T (2019) Microglia in retinal degeneration. Front Immunol 10:1975. https://doi.org/10.3389/fimmu.2019.01975
Naylor A, Hopkins A, Hudson N, Campbell M (2019) Tight junctions of the outer blood retina barrier. Int J Mol Sci 21(1):211. https://doi.org/10.3390/ijms21010211
Lewis GP, Sethi CS, Carter KM, Charteris DG, Fisher SK (2005) Microglial cell activation following retinal detachment: a comparison between species. Mol Vis 11:491–500
Ivert L, Kjeldbye H, Gouras P (2002) Long-term effects of short-term retinal bleb detachments in rabbits. Graefes Arch Clin Exp Ophthalmol 240:232–237. https://doi.org/10.1007/s00417-001-0392-4
Szurman P, Roters S, Grisanti S, Aisenbrey S, Schraermeyer U, Luke M, Bartz-Schmidt KU, Thumann G (2006) Ultrastructural changes after artificial retinal detachment with modified retinal adhesion. Invest Ophthalmol Vis Sci 47:4983–4989. https://doi.org/10.1167/iovs.06-0491
Bartuma H, Petrus-Reurer S, Aronsson M, Westman S, Andre H, Kvanta A (2015) In vivo imaging of subretinal bleb-induced outer retinal degeneration in the rabbit. Invest Ophthalmol Vis Sci 56:2423–2430. https://doi.org/10.1167/iovs.14-16208
Hiscott P, Sheridan C, Magee RM, Grierson I (1999) Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 18:167–190. https://doi.org/10.1016/S1350-9462(98)00024-X
Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178–196. https://doi.org/10.1038/nrm3758
Kivela T, Uusitalo M (1998) Structure, development and function of cytoskeletal elements in non-neuronal cells of the human eye. Prog Retin Eye Res 17:385–428. https://doi.org/10.1016/s1350-9462(98)00001-9
Arimura N, Ki-i Y, Hashiguchi T, Kawahara K, Biswas KK, Nakamura M, Sonoda Y, Yamakiri K, Okubo A, Sakamoto T, Maruyama I (2009) Intraocular expression and release of high-mobility group box 1 protein in retinal detachment. Lab Invest 89:278–289. https://doi.org/10.1038/labinvest.2008.165
Arroyo JG, Yang L, Bula D, Chen DF (2005) Photoreceptor apoptosis in human retinal detachment. Am J Ophthalmol 139:605–610. https://doi.org/10.1016/j.ajo.2004.11.046
Wickham L, Lewis G, Charteris D, Fisher S (2013) Cellular effects of detachment and reattachment on the neural retina and the retinal pigment epithelium. Retina 605–617
Lewis GP, Chapin EA, Luna G, Linberg KA, Fisher SK (2010) The fate of Muller’s glia following experimental retinal detachment: nuclear migration, cell division, and subretinal glial scar formation. Mol Vis 16:1361–1372
Lopez PF, Yan Q, Kohen L, Rao NA, Spee C, Black J, Oganesian A (1995) Retinal pigment epithelial wound healing in vivo. Arch Ophthalmol 113:1437–1446. https://doi.org/10.1001/archopht.1995.01100110097032
Leonard DS, Zhang XG, Panozzo G, Sugino IK, Zarbin MA (1997) Clinicopathologic correlation of localized retinal pigment epithelium debridement. Invest Ophthalmol Vis Sci 38:1094–1109
Lane C, Boulton M, Marshall J (1989) Transplantation of retinal pigment epithelium using a pars plana approach. Eye 3:27–32. https://doi.org/10.1038/eye.1989.4
Petrus-Reurer S, Bartuma H, Aronsson M, Westman S, Lanner F, Andre H, Kvanta A (2017) Integration of subretinal suspension transplants of human embryonic stem cell-derived retinal pigment epithelial cells in a large-eyed model of geographic atrophy. Invest Ophthalmol Vis Sci 58:1314–1322. https://doi.org/10.1167/iovs.16-20738
Koh AE, Alsaeedi HA, Rashid MBA, Lam C, Harun MHN, Saleh M, Luu CD, Kumar SS, Ng MH, Isa HM, Leow SN, Then KY, Bastion MC, Ali Khan MS, Mok PL (2019) Retinal degeneration rat model: a study on the structural and functional changes in the retina following injection of sodium iodate. J Photochem Photobiol B 196:111514. https://doi.org/10.1016/j.jphotobiol.2019.111514
Plaza Reyes A, Petrus-Reurer S, Antonsson L, Stenfelt S, Bartuma H, Panula S, Mader T, Douagi I, Andre H, Hovatta O, Lanner F, Kvanta A (2016) Xeno-free and defined human embryonic stem cell-derived retinal pigment epithelial cells functionally integrate in a large-eyed preclinical model. Stem Cell Reports 6:9–17. https://doi.org/10.1016/j.stemcr.2015.11.008
Ilmarinen T, Thieltges F, Hongisto H, Juuti-Uusitalo K, Koistinen A, Kaarniranta K, Brinken R, Braun N, Holz FG, Skottman H, Stanzel BV (2019) Survival and functionality of xeno-free human embryonic stem cell-derived retinal pigment epithelial cells on polyester substrate after transplantation in rabbits. Acta Ophthalmol 97:e688–e699. https://doi.org/10.1111/aos.14004
Stanzel BV, Liu Z, Somboonthanakij S, Wongsawad W, Brinken R, Eter N, Corneo B, Holz FG, Temple S, Stern JH, Blenkinsop TA (2014) Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Reports 2:64–77. https://doi.org/10.1016/j.stemcr.2013.11.005
Los LI, van Luyn MJ, Nieuwenhuis P (1999) Organization of the rabbit vitreous body: lamellae, Cloquet’s channel and a novel structure, the “alae canalis Cloqueti.” Exp Eye Res 69:343–350. https://doi.org/10.1006/exer.1999.0708
Acknowledgements
We thank Dr. Loic Sermois for helpful support with OCT imaging of animals. Further, Els van Haver (Medanex) is most gratefully acknowledged for a very smooth surgical and animal support. Geuder AG, Heidelberg, Germany, had provided a Megatron S4 vitrectomy machine with consumables at no cost for the duration of the surgeries in exchange for acquiring internal software and hardware test data. Dr. Stanzel holds an EU patent (EP 2 825 108 B1) on the sling instrument for RPE removal cited herein.
Funding
Open Access funding enabled and organized by Projekt DEAL. B. V. Stanzel: DFG STA 1135/2–1, BMBF ReSight Consortium TP3 01EK1613A; all others: none.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
All procedures were conducted in Belgium and approved by the state regulatory authorities of Belgium study code 18–080 and were in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
Geuder (F, C, P), Zeiss (F), MedOne Surgical Inc. (F). All other authors declare that they have no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file4 (MPEG 15604 KB)
Supplementary file5 (M4V 13620 KB)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Al-Nawaiseh, S., Krötz, C., Rickmann, A. et al. A rabbit model for outer retinal atrophy caused by surgical RPE removal. Graefes Arch Clin Exp Ophthalmol 261, 2265–2280 (2023). https://doi.org/10.1007/s00417-023-06014-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-023-06014-3